ULTRAGENYX PHARMACEUTICAL
Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist. The management team's experience in selecting and developing products with clear mechanisms of action for untreated rare diseases will help Ultragenyx create life-changing therapeutics by leveraging existing yet undeveloped science for these little-known indications.
ULTRAGENYX PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Novato, California, United States
Country:
United States
Website Url:
http://www.ultragenyx.com
Total Employee:
501+
Status:
Active
Contact:
+1 415 483 8800
Email Addresses:
[email protected]
Total Funding:
1.14 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Content Delivery Network Amazon Font Awesome
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA specializes in the development of women's health care products.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Santhera Pharmaceuticals
Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.
Surrozen
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Versiti
Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
AlloVir
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-18 | GeneTx Biotherapeutics | GeneTx Biotherapeutics acquired by Ultragenyx Pharmaceutical | 75 M USD |
| 2017-09-18 | Dimension Therapeutics | Dimension Therapeutics acquired by Ultragenyx Pharmaceutical | 152.3 M USD |
Investors List
Takeda Ventures
Takeda Ventures investment in Post-IPO Equity - Ultragenyx Pharmaceutical
Takeda
Takeda investment in Post-IPO Equity - Ultragenyx Pharmaceutical
F-Prime Capital
F-Prime Capital investment in Series B - Ultragenyx Pharmaceutical
Adage Capital Management
Adage Capital Management investment in Series B - Ultragenyx Pharmaceutical
HealthCap
HealthCap investment in Series B - Ultragenyx Pharmaceutical
Pappas Ventures
Pappas Ventures investment in Series B - Ultragenyx Pharmaceutical
TPG Growth
TPG Growth investment in Series B - Ultragenyx Pharmaceutical
BlackRock Private Equity Partners
BlackRock Private Equity Partners investment in Series B - Ultragenyx Pharmaceutical
HealthCap
HealthCap investment in Series A - Ultragenyx Pharmaceutical
F-Prime Capital
F-Prime Capital investment in Series A - Ultragenyx Pharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-10-23 | Solid Biosciences | Ultragenyx Pharmaceutical investment in Post-IPO Equity - Solid Biosciences | 40 M USD |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2023-07-12 | Ultragenyx Pharmaceutical appoints CFO |
| 2023-03-14 | Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President |
| 2022-11-10 | Ultragenyx Announces Departure of Chief Financial Officer |
Official Site Inspections
http://www.ultragenyx.com Semrush global rank: 1.03 M Semrush visits lastest month: 26.72 K
- Host name: 104.18.26.199
- IP address: 104.18.26.199
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ultragenyx Pharmaceutical"
Ultragenyx - Wikipedia
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic …See details»
Ultragenyx | Rare Disease Medical Research | Now Enrolling
Ultragenyx is dedicated to improving life for people with rare and ultra-rare diseases, and their family and caregivers, through the creation and discovery of much-needed therapies.See details»
Ultragenyx Company Profile | Management and Employees List
Ultragenyx Profile and History Ultragenyx is a biopharmaceutical company founded in 2010 that focuses on developing treatments for rare and ultra-rare genetic diseases. The company …See details»
Ultragenyx Pharmaceutical - Crunchbase Company …
Ultragenyx Pharmaceutical focuses on the development of various products for …See details»
Ultragenyx Patient Advocacy - Rare and UltraRare …
At Ultragenyx, we strive to incorporate patient & family voices into everything we do. We're passionate about supporting those with rare & ultra-rare diseases.See details»
Talent Network - Talent Network
Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering …See details»
Leadership—Ultragenyx
Ultragenyx is led by a passionate biopharmaceutical management team that combines deep expertise in drug development and commercialization.See details»
Corporate Responsibility—Ultragenyx
The sustainability and corporate responsibility of Ultragenyx is exemplified by expedited drug development, efforts to improve access, and a people-first …See details»
Join Our Team—Ultragenyx
At Ultragenyx, we have a talented team that shares a passion for helping patients with rare diseases and a vibrant, people-first culture. Join us.See details»
Beyond Words on Walls: How Living Values Built a
Jun 10, 2025 Leaving my management consulting career for a full-time role with Ultragenyx wasn’t part of my plan. Yet, I can see now that I couldn’t have designed it better. This move …See details»
Research—Ultragenyx
Ultragenyx focuses its scientific research on developing life-changing therapies for patients with serious rare and ultrarare genetic diseases.See details»
Ultragenyx Receives Breakthrough Therapy Designation for …
NOVATO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel …See details»
Rare Bootcamp
The Rare Bootcamp is a multi-day forum hosted by Ultragenyx and EveryLife Foundation for Rare Diseases to provide parents and other patient advocates seeking to develop rare disease …See details»
Ultragenyx Mission, Benefits, and Work Culture | Indeed.com
Come see what’s going on inside Ultragenyx, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make people want to work …See details»
Ultragenyx Receives Complete Response Letter from FDA for
3 days ago About Ultragenyx Ultragenyx is a biopharmaceutical company committed to bringing novel therapies to patients for the treatment of serious rare and ultra-rare genetic diseases.See details»
US FDA declines to approve Ultragenyx's gene therapy for rare …
3 days ago The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat a rare inherited disorder, citing …See details»
How Leaders At Ultragenyx Balance The Duality Of ‘Action ... - Forbes
Mar 3, 2023 Example of Ultragenyx values mapped out to behaviors for self, team, and organization. Ultragenyx Their map of key behaviors then drove the topics for their leadership …See details»
Understanding Gene Therapy - Ultragenyx
At Ultragenyx, we adhere to strict regulatory standards with our manufacturing partners. Our state-of-the-art facility and proprietary platform allow us to conduct end-to-end research, …See details»
FDA rejects Ultragenyx gene therapy over manufacturing concerns
1 day ago The Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical’s experimental gene therapy for a rare neurodegenerative disorder, citing …See details»
Ultragenyx Receives Complete Response Letter from FDA for …
3 days ago Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are resolvable FDA clinical reviews acknowledged …See details»